Torrent Pharma Financial Statements

Torrent Pharma (TORNTPHARM) reported revenue of ₹115.39B in FY2025 with net income of ₹19.11B. Total assets stood at ₹149.90B and free cash flow was ₹19.73B.

Torrent Pharma Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		80.05B	87.05B	96.65B	107.86B	115.39B
Cost of Rev. Cost of Revenue		-21.47B	-24.43B	-27.35B	-26.86B	-33.26B
Gross Profit		58.58B	62.62B	69.30B	81.00B	82.13B
SGA Sales, General & Admin		-33.73B	-36.34B	-40.43B	-46.74B	-50.19B
Op. Income Operating Income		18.27B	19.66B	21.80B	26.18B	23.99B
PBT Profit Before Tax		15.26B	12.26B	18.47B	23.52B	26.73B
Net Income		12.52B	7.77B	12.45B	16.56B	19.11B
Dil. Shares Diluted Shares		338.45M	338.45M	338.45M	338.45M	338.41M
Diluted EPS		36.99	22.96	36.79	48.94	56.47

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Torrent Pharma's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Torrent Pharma Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		55.22B	51.65B	53.14B	56.11B	56.23B
Non-curr. assets Total non-current assets		85.53B	79.35B	96.98B	94.49B	93.67B
Total assets		140.75B	131.00B	150.12B	150.61B	149.90B
Curr. liabilities Total current liabilities		48.91B	44.15B	54.47B	54.25B	47.17B
Non-curr. liab. Total non-current liabilities		33.46B	27.32B	33.66B	27.79B	26.82B
Total liabilities		82.37B	71.47B	88.14B	82.04B	73.99B
Total equity		58.38B	59.53B	61.98B	68.56B	75.91B
Total liab. & eq. Total liabilities & equity		140.75B	131.00B	150.12B	150.61B	149.90B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Torrent Pharma's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Torrent Pharma Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		15.26B	12.26B	18.47B	23.52B	26.73B
Operating CF Cash flow Operating Activities		20.11B	18.03B	23.68B	32.66B	25.85B
Capex Investments in PPE		-3.35B	-2.03B	-5.74B	-4.33B	-6.12B
Investing CF Cash flow Investing Activities		-4.49B	-1.98B	-23.56B	-1.68B	-5.40B
Dividend Paid		-3.38B	-6.77B	-8.63B	-10.15B	-10.83B
Financing CF Cash flow Financing Activities		-16.56B	-17.81B	770.00M	-27.79B	-22.98B
Cash (start) Cash at beginning of period		6.62B	5.73B	3.98B	5.08B	8.35B
Cash (end) Cash at end of period		5.73B	3.98B	5.08B	8.35B	5.73B
FCF Free Cash Flow		16.76B	16.00B	17.94B	28.33B	19.73B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Torrent Pharma's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025